Michael ZürcherOct 142 min readINSIGHTSOrphan Drug Designation: Key differences between Switzerland and the EU
Michael ZürcherAug 271 min readSWIZZARD CHAMPIONSUnlock the Secrets to Building a Successful International Biotech HQ!
Michael ZürcherJul 231 min readINSIGHTSExciting news from Swizzard—we’ve just welcomed our 35th client!
Michael ZürcherJul 91 min readINSIGHTSFrom early access to national reimbursement – your partner for Swiss market access
Michael ZürcherJul 12 min readTEAM & PARTNERSLinus Schneeberger joins Swizzard as Business Analyst & Business Technology Leader
Michael ZürcherMay 12 min readTEAM & PARTNERSAnnabelle Müller joins Swizzard as Market Access Director
Michael ZürcherMar 191 min readINSIGHTSSuccess factors for foreign players entering the Swiss pharmaceuticals market
